TP53 and ovarian cancer: The expression of miR-22 is increased in human senescent fibroblasts and epithelial cells and targets PTEN, p21, and p53, but it is decreased in a variety of cancer cells such as colon cancer, liver cancer, ovarian cancer, and breast cancer cells [33]–[36].